CLINICAL STUDY EVALUATING TREATMENT OF DIABETIC FOOT ULCERS USING MICROCYN TECHNOLOGY PRESENTED AT STUTTGART2005
Oculus Innovative Sciences announced that Luca Dalla Paola, a surgeon with the
diabetic foot unit of the Abano Terme Hospital in Italy, recently presented
the results of a 218-patient controlled clinical study that assessed the safety
and efficacy of Microcyn Technology in treating diabetic foot ulcers as compared
to povidone iodine (10%) antiseptic, which is often used as the "standard
care" in treatment of open wounds.